Excellent Survival Outcomes for NET Patients Treated within NETwerk, a Collaborative ENETS Center of Excellence

#2079

Introduction: Since 2016, patients with neuroendocrine tumors (NETs) of 9 hospitals in Belgium, are jointly discussed during multidisciplinary tumor boards (NET MDT) within NETwerk, a ENETS Center of Excellence.

Aim(s): To describe patient population and 5-year overall survival of NETs diagnosed within NETwerk from 2011 to 2017.

Materials and methods: Pathological incidence date (or, if not available, diagnosis on imaging), date of death, sex, tumor grade (WHO 2010) and stage (WHO TNM 7th edition) and age at diagnosis were collected. Overall survival rates were calculated.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Vandamme T

Authors: Vandamme T, Maurissen I, Lybaert W, Simoens M, Abrams P,

Keywords: Neuroendocrine tumors, Care networking,